Mendus AB (publ) (IMMU) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.139x

Based on the latest financial reports, Mendus AB (publ) (IMMU) has a cash flow conversion efficiency ratio of -0.139x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-81.53 Million ≈ $-8.77 Million USD) by net assets (Skr585.07 Million ≈ $62.96 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Mendus AB (publ) - Cash Flow Conversion Efficiency Trend (2010–2025)

This chart illustrates how Mendus AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Mendus AB (publ) for a breakdown of total debt and financial obligations.

Mendus AB (publ) Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Mendus AB (publ) ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Gabriel Resources Ltd V:GBU	0.080x
Acarix A/S ST:ACARIX	-0.442x
Inbest Prime IV Inmuebles SOCIMI S.A. MC:YINB4	N/A
POLARIS WORKS Inc KQ:123010	0.019x
Sterling Metals Corp V:SAG	-0.027x
Subur Tiasa Holdings Bhd KLSE:6904	0.094x
Puloon Technology Inc KQ:094940	-0.019x
Atende S.A. WAR:ATD	-0.165x

Annual Cash Flow Conversion Efficiency for Mendus AB (publ) (2010–2025)

The table below shows the annual cash flow conversion efficiency of Mendus AB (publ) from 2010 to 2025. For the full company profile with market capitalisation and key ratios, see Mendus AB (publ) (IMMU) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr585.07 Million ≈ $62.96 Million	Skr-81.53 Million ≈ $-8.77 Million	-0.139x	-12.85%
2024-12-31	Skr645.15 Million ≈ $69.43 Million	Skr-79.67 Million ≈ $-8.57 Million	-0.123x	+46.53%
2023-12-31	Skr704.73 Million ≈ $75.84 Million	Skr-162.76 Million ≈ $-17.52 Million	-0.231x	-8.67%
2022-12-31	Skr514.44 Million ≈ $55.36 Million	Skr-109.33 Million ≈ $-11.77 Million	-0.213x	-1.12%
2021-12-31	Skr656.74 Million ≈ $70.68 Million	Skr-138.03 Million ≈ $-14.85 Million	-0.210x	-145.38%
2020-12-31	Skr661.09 Million ≈ $71.14 Million	Skr-56.63 Million ≈ $-6.09 Million	-0.086x	+83.98%
2019-12-31	Skr272.78 Million ≈ $29.36 Million	Skr-145.81 Million ≈ $-15.69 Million	-0.535x	-107.36%
2018-12-31	Skr406.04 Million ≈ $43.70 Million	Skr-104.67 Million ≈ $-11.26 Million	-0.258x	-5.20%
2017-12-31	Skr189.56 Million ≈ $20.40 Million	Skr-46.45 Million ≈ $-5.00 Million	-0.245x	+25.64%
2016-12-31	Skr102.39 Million ≈ $11.02 Million	Skr-33.74 Million ≈ $-3.63 Million	-0.330x	-14.00%
2015-12-31	Skr139.18 Million ≈ $14.98 Million	Skr-40.23 Million ≈ $-4.33 Million	-0.289x	+53.42%
2014-12-31	Skr64.63 Million ≈ $6.95 Million	Skr-40.10 Million ≈ $-4.32 Million	-0.621x	-570.22%
2013-12-31	Skr100.24 Million ≈ $10.79 Million	Skr-9.28 Million ≈ $-998.77K	-0.093x	+68.12%
2012-12-31	Skr24.60 Million ≈ $2.65 Million	Skr-7.15 Million ≈ $-769.03K	-0.290x	+31.50%
2011-12-31	Skr7.63 Million ≈ $820.73K	Skr-3.23 Million ≈ $-347.98K	-0.424x	+0.26%
2010-12-31	Skr3.92 Million ≈ $421.83K	Skr-1.67 Million ≈ $-179.31K	-0.425x	--

About Mendus AB (publ)

ST:IMMU Sweden Biotechnology

Market Cap

$33.83 Million

Skr314.38 Million SEK

Market Cap Rank

#23308 Global

#446 in Sweden

Share Price

Skr5.13

Change (1 day)

+4.91%

52-Week Range

Skr3.96 - Skr10.02

All Time High

Skr737.49